U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421076) titled 'Grid eXplore Mapping Study' on Feb. 12.
Brief Summary: The purpose of the trial is to find out if the Grid X Mapping Catheter and EnSite X EP System with EnSite X Software v3.1.1, the devices that are being studied, are safe and effective in treating Chinese patients who have atrial fibrillation.
Participants will receive a procedure called catheter mapping and ablation to treat their abnormal heart rhythms and are required to complete 4 follow-up visits at 7 days, 3 months, 6 months and 12 months after the procedure for checkups and tests.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Paroxysmal Atrial Fibri...